KCT0002691已完成未知
Determination of EC95 of remifentanil for smooth emergence from sevoflurane anesthesia in patients undergoing trans-femoral cerebral angiography
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 70(Year)（—）
- 性别
- All
入选标准
- •Adults undergoing TFCA because of cerebrovascular disease ( age from 20 to70 years )
- •ASA class I - III
- •patients who agree to the clinical trial and signs written informed consent
排除标准
- •- Symptoms or signs of increased intracranial pressure
- •- uncontrolled hypertension
- •- preoperative administration of an antitussive agent
- •- patients with gastroesophageal reflux
- •- allergic history with use of remifentanil or contraindication for remifentanil
- •- patients with arrythmia or congestive heart failure (new York heart association heart failure grade 3,4)
- •- Acute or chronic respiratory disease or patients who require ventilator care after Trans-femoral cerebral angiography
- •(Bronchial asthma, chronic obstructive lung disease, upper respiratory infection within 2 weeks etc.)
- •- severe obesity (BMI > 35 kg/m2)
- •- severe obstructive sleep apnea
- •- anticipated difficult airway
- •- A person who does not recover consciousness 20 minutes after discontinuing sevoflurane administration
- •(Consider delayed emergence and exclude the patient from trial)
- •- Patients who are judged to be inadequate to participate in clinical trials at the discretion of the researcher
- •- Patients who do not agree to participate in the study
研究者
相似试验
已完成
不适用
ED50 and ED95 of Remifentanil for Intubation Without NOL VariationDifficult or Failed IntubationNCT03744949Ciusss de L'Est de l'Île de Montréal80
已完成
不适用
The optimum bolus dose of remifentanil to facilitate laryngeal mask airway insertion with a single standard dose of propofol in elderly patientsDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0000088Seoul National University Bundang Hospital30
进行中（未招募）
不适用
Study to evaluate the optimal dose of remifentanil infusion(effective dose in 80% of patients) required to ensure apnoea (of 30 seconds duration) during magnetic resonance imaging of the heart under general anaesthesia in children aged 1 to 6 years.Study refers to the use of this medicine during anaesthesia given during the investigation of congenital heart disease.EUCTR2014-004346-10-GBAlder Hey Children's NHS Foundation Trust
已完成
不适用
The Optimal Concentration of Remifentanil for the i-gel Insertion in Simulated Difficult Airway PatientsInjury, poisoning and certain other consequences of external causesKCT0000924Hanyang University Guri Hospital47
已完成
不适用
The optimum bolus dose of remifentanil to faciliate intubating conditions with a single standard dose of propofol in elderly patientsDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0000105Seoul National University Bundang Hospital30